Identification and functional characterization of novel CYP2J2 allele in a Korean population

被引：0
|
作者：
Lee, SS
Jung, HE
Jang, JE
Kim, MJ
Liu, KH
Shin, JG
机构：
[1] Inje Univ, Dept Pharmacol, Pusan, South Korea
[2] Inje Univ, Pharmacogenom Res Ctr, Pusan, South Korea
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
135
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] A novel functional genetic variant of CYP2J2 in a Korean population.
    Ryu, J
    Jung, H
    Liu, K
    Lee, S
    Cha, I
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P94 - P94
  • [2] Cloning of CYP2J2 gene and identification of functional polymorphisms
    King, LM
    Ma, JX
    Srettabunjong, S
    Graves, J
    Bradbury, JA
    Li, LP
    Spiecker, M
    Liao, JK
    Mohrenweiser, H
    Zeldin, DC
    MOLECULAR PHARMACOLOGY, 2002, 61 (04) : 840 - 852
  • [3] Cloning of the CYP2J2 gene and identification of polymorphisms
    King, LM
    Ma, JX
    Srettabunjong, S
    Li, LP
    Zeldin, DC
    FASEB JOURNAL, 2000, 14 (08): : A1437 - A1437
  • [4] Analysis of CYP2J2 mutations in the Chinese Uyghur population
    Li, Haiyue
    He, Yongjun
    Wang, Li
    Xing, Shishi
    Peng, Linna
    Yuan, Dongya
    Jin, Tianbo
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10871 - 10881
  • [5] Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity
    Lee, SS
    Jeong, HE
    Liu, KH
    Ryu, JY
    Moon, T
    Yoon, CN
    Oh, SJ
    Yun, CH
    Shin, JG
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (02): : 105 - 113
  • [6] Molecular cloning and characterization of the novel CYP2J2 in dromedary camels (Camelus dromedarius)
    Kamel, Shaimaa
    Ibrahim, Marwa A.
    Awad, ElSaid T.
    El-Hindi, Hatim M. A.
    Abdel-Aziz, Samy A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 120 : 1770 - 1776
  • [7] The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2
    Tian, Xiangge
    Zhou, Meirong
    Ning, Jing
    Deng, Xiaopeng
    Feng, Lei
    Huang, Huilian
    Yao, Dahong
    Ma, Xiaochi
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 737 - 748
  • [8] CHARACTERIZATION OF ANTIHYPERTENSIVE DRUGS AS POTENT INHIBITORS OF CYP2J2
    Yamaori, Satoshi
    Ikemura, Noriaki
    Kobayashi, Chinatsu
    Kamijo, Shinobu
    Ohmori, Shigeru
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S46 - S46
  • [9] CYP2J2*7 single nucleotide polyrnorphism in a Chinese population
    Wang, HJ
    Jiang, Y
    Liu, Y
    Lin, CZ
    Cheng, G
    Chen, XP
    Hao, BT
    Tan, W
    Lin, DX
    He, FC
    CLINICA CHIMICA ACTA, 2006, 365 (1-2) : 125 - 128
  • [10] A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China
    Zhu, Qing
    Fu, Zhenyan
    Ma, Yitong
    Yang, Hong
    Huang, Ding
    Xie, Xiang
    Liu, Fen
    Zheng, Yingying
    Cha, Erdenbat
    CLINICAL BIOCHEMISTRY, 2013, 46 (12) : 1047 - 1054
12345